US FDA approves Takeda, Protagonist’s drug for rare blood cancer
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
Regulatory Approvals
FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare…
FDA approves new COVID vaccines
FDA approves new COVID vaccines CIDRAP
FDA approves updated Covid-19 vaccines for dominant XFG variant
FDA approves updated Covid-19 vaccines for dominant XFG variant The Guardian
FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis
FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis The American Journal of Managed Care